Related Experiment Video
Updated: Apr 29, 2026
06:13
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
17.3K
How I treat sinusoidal obstruction syndrome
1Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC.
Blood
|May 17, 2014
Summary
Sinusoidal obstruction syndrome (SOS), a complication following hematopoietic cell transplantation (HCT), requires ongoing attention. This review covers prophylaxis, diagnosis, and therapy for SOS in HCT patients.
Area of Science:
- Hematology
- Transplantation Medicine
- Oncology
Background:
- Sinusoidal obstruction syndrome (SOS), formerly known as veno-occlusive disease (VOD), is a significant complication post-hematopoietic cell transplantation (HCT).
- The incidence of SOS has evolved with advancements in allogeneic HCT.
- Changing HCT indications and patient comorbidities necessitate continued focus on SOS management.
Observation:
- SOS presents a persistent challenge in HCT supportive care.
- Older and more medically complex patients are increasingly undergoing HCT.
- Effective prophylaxis and treatment strategies are crucial for managing SOS.
Findings:
- This discussion addresses the multifaceted approach to managing SOS.
- Key areas covered include preventative measures, diagnostic methods, and therapeutic interventions.
- The evolving landscape of HCT impacts the presentation and management of SOS.
Implications:
- Optimizing SOS prophylaxis and treatment is vital for improving HCT outcomes.
- Understanding SOS is essential for clinicians caring for HCT recipients.
- Further research into SOS diagnosis and therapy may enhance patient survival and quality of life.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
01:21Drugs for Treatment of Constipation-Predominant IBS
1.4K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K
01:26Mitral Stenosis III: Medical Management
532
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
532
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:26Tonsillitis II: Management
677
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
677
01:24Cystic Fibrosis: Management
657
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
657